Bioxcel Therapeutics, Inc. (BTAI)

Last Year

23-Nov-23 -- 22-Nov-24

Time Period:

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Other

Other

Sentiment Breakdown by Insider

0

(3)

0

(2)

1

(1)

4

0

5

+1

0

+2

0

+3

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
17-Sep-24 7:23 PM View:	16-Sep-24 Planned Option Sale ($0.24K)	Yocca Frank Chief Scientific Officer		Bioxcel Therapeutics, Inc. - BTAI	35% 10.54K to 14.2K	0	0	--	--	Show Txns Hide Txns

17-Sep-24 7:20 PM View:	16-Sep-24 Planned Option Sale ($0.24K)	Rodriguez Javier See Remarks		Bioxcel Therapeutics, Inc. - BTAI	69% 5.39K to 9.13K	0	0	--	--	Show Txns Hide Txns

17-Sep-24 7:18 PM View:	16-Sep-24 Planned Option Sale ($0.15K)	Wiley Matthew T. CHIEF COMMERCIAL OFFICER		Bioxcel Therapeutics, Inc. - BTAI	100% 0 to 4.03K	0	0	--	--	Show Txns Hide Txns

17-Sep-24 7:21 PM View:	16-Sep-24 Planned Option Sale ($0.25K)	Steinhart Richard I Chief Financial Officer		Bioxcel Therapeutics, Inc. - BTAI	144% 2.54K to 6.2K	0	0	--	--	Show Txns Hide Txns

17-Sep-24 7:19 PM View:	16-Sep-24 Planned Option Sale ($95.33)	O'Neill Vincent See Remarks		Bioxcel Therapeutics, Inc. - BTAI	71% 2.28K to 3.91K	0	0	--	--	Show Txns Hide Txns

17-Sep-24 7:21 PM View:	16-Sep-24 Planned Option Sale ($1.37K)	Mehta Vimal CEO and President Director 10% Owner		Bioxcel Therapeutics, Inc. - BTAI	(10%) 8.58M to 7.74M	0	0	--	--	Show Txns Hide Txns